Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/9/06 → 09/30/10 |
Funding
- Pfizer Incorporated: $65,067.20
Six Week, Double Blind, Placebo Controlled Phase III Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of Flexible Doses of Oral Ziprasidone in Adolescent Subjects with Schizophrenia
- Kaye, David (PI)
- Cummings, Michael (CoI)
- Waxmonsky, James (CoI)
Project: Research